'Chemical Nose' to Sniff Out Cancer Earlier, Improve Treatment Options

Jun 23, 2009
'Chemical Nose' to Sniff Out Cancer Earlier, Improve Treatment Options

(PhysOrg.com) -- Using a "chemical nose" array of nanoparticles and polymers, researchers at the University of Massachusetts Amherst have developed a fundamentally new, more effective way to differentiate not only between healthy and cancerous cells but also between metastatic and non-metastatic cancer cells. It’s a tool that could revolutionize cancer detection and treatment, according to chemist Vincent Rotello and cancer specialist Joseph Jerry.

An article describing Rotello and colleagues’ new chemical nose method of appears in the June 23 issue of the journal Proceedings of the National Academy of Science online.

Currently, detecting cancer via cell surface biomarkers has taken what’s known as the “lock and key” approach. Drawbacks of this method include that foreknowledge of the biomarker is required. Also, as Rotello explains, a cancer cell has the same biomarkers on its surface as a healthy cell, but in different concentrations, a maddeningly small difference that can be very difficult to detect. “You often don’t get a big signal for the presence of cancer,” he notes. “It’s a subtle thing.”

He adds, “Our new method uses an array of sensors to recognize not only known cancer types, but it signals that are present. That is, the chemical nose can simply tell us something isn’t right, like a ‘check engine light,’ though it may never have encountered that type before.” Further, the chemical nose can be designed to alert doctors of the most types, those for which early treatment is crucial.

In blinded experiments in four human cancer cell lines (cervical, liver, testis and breast), as well as in three metastatic breast cell lines, and in normal cells, the new detection technique correctly indicated not only the presence of cancer cells in a sample but also identified primary cancer vs. metastatic disease.

In further experiments to rule out the possibility that the chemical nose had simply detected individual differences in cells from different donors, the researchers repeated the experiments in skin cells from three groups of cloned BALB /c mice: healthy animals, those with primary cancer and those with metastatic disease. Once again, it worked. “This result is key,” says Rotello. “It shows that we can differentiate between the the three cell types in a single individual using the chemical nose approach.”

Rotello’s research team, with colleagues at the Georgia Institute of Technology, designed the new detection system by combining three gold nanoparticles that have special affinity for the surface of chemically abnormal cells, plus a polymer known as PPE, or para-phenyleneethynylene. As the ‘check engine light,’ PPE fluoresces or glows when displaced from the nanoparticle surface.

By adding PPE bound with gold nanoparticles to human cells incubating in wells on a culture plate, the researchers induce a response called “competitive binding.” Cell surfaces bind the nanoparticles, displacing the PPE from the surface. This turns on PPE’s fluorescent switch. Cells are then identified from the patterns generated by different particle-PPE systems.

Rotello says the chemical nose approach is so named because it works like a human nose, which is arrayed with hundreds of very selective chemical receptors. These bind with thousands of different chemicals in the air, some more strongly than others, in the endless combination we encounter. The receptors report instantly to the brain, which recognizes patterns such as, for example, “French fries,” or it creates a new smell pattern.

Chemical receptors in the nose plus the brain’s pattern recognition skills together are incredibly sensitive at detecting subtly different combinations, Rotello notes. We routinely detect the presence of tiny numbers of bacteria in meat that’s going bad, for instance. Like a human nose, the chemical version being developed for use in cancer also remembers patterns experienced, even if only once, and creates a new one when needed.

For the future, Rotello says further studies will be undertaken in an animal model to see if the chemical nose approach can identify cell status in real tissue. Also, more work is required to learn how to train the chemical nose’s sensors to give more precise information to physicians who will be making judgment calls about patients’ treatment. But the future is promising, he adds. “We’re getting complete identification now, and this can be improved by adding more and different nanoparticles. So far we’ve experimented with only three, and there are hundreds more we can make.”

Provided by University of Massachusetts Amherst (news : web)

Explore further: Nano-sized chip "sniffs out" explosives far better than trained dogs

add to favorites email to friend print save as pdf

Related Stories

Gold Nanoparticles May Simplify Cancer Detection

May 09, 2005

Binding gold nanoparticles to a specific antibody for cancer cells could make cancer detection much easier, suggests research at the Georgia Institute of Technology and the University of California at San ...

NASA's ENose can sense brain cancer cells

Apr 30, 2009

(PhysOrg.com) -- An unlikely multidisciplinary scientific collaboration has discovered that an electronic nose developed for air quality monitoring on Space Shuttle Endeavour can also be used to detect odour differences in ...

Nanorods show benefits cancer treatment

Mar 14, 2006

Researchers at the Georgia Institute of Technology and the University of California, San Francisco, have found an even more effective and safer way to detect and kill cancer cells. By changing the shapes of ...

Caltech Electronic Nose Innovation

Oct 22, 2007

Research Scientists at Caltech Developing Electronic Nose. The Chemistry and Chemical Engineering Division at Caltech are combining efforts with NASA and other engineers at Caltech to test ranges of applications.

Gold nanoparticles may pan out as tool for cancer diagnosis

Jul 31, 2007

When it comes to searching out cancer cells, gold may turn out to be a precious metal. Purdue University researchers have created gold nanoparticles that are capable of identifying marker proteins on breast cancer cells, ...

Recommended for you

A new approach to creating organic zeolites

Jul 24, 2014

Yushan Yan, Distinguished Professor of Engineering at the University of Delaware, is known worldwide for using nanomaterials to solve problems in energy engineering, environmental sustainability and electronics.

A tree may have the answers to renewable energy

Jul 23, 2014

Through an energy conversion process that mimics that of a tree, a University of Wisconsin-Madison materials scientist is making strides in renewable energy technologies for producing hydrogen.

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

RafeFurst
not rated yet Aug 22, 2009
What I like about this approach is that if you can distinguish individual malignant cells from non-malignant in vivo, you can then rather easily remove them from the body without collateral damage. Almost all other approaches to detection punt on specificity, look for gross regions (which contain many normal cells), and are not nearly comprehensive. You need both specificity and comprehensiveness to stop cancer. Of course, it's the trillion dollar question as to whether you can actually achieve both with this (or any) detection approach.